Can Acupoint Low Intensity Shockwave Therapy Improve Bladder Voiding Efficiency: A Pilot Study.

Status: Recruiting
Location: See location...
Intervention Type: Drug, Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

With the increasing of the elderly population, patients with urinary dysfunction caused by inefficiency of bladder emptying becomes much often than before. However, the current treatments for this kind of bladder dysfunction are limited and unsatisfactory. Low-intensity extracorporeal shockwave therapy (LiESWT) is a very popular emerging treatment in recent years, and abundant of literatures have confirmed that this treatment is safe and effective in myofascial pain and male erectile dysfunction. Recently, many animal experiments have showed that LiESWT could improve urinary dysfunction caused by bladder dysfunction. Taiwan based studies also reported that LiESWT could improve symptoms of overactive bladder. LiESWT is a non-drug, low-invasive and high-safety treatment, which is very suitable for elderly patients. In this study investigator combine the LiESWT and acupuncture to treat the patients with underactive bladder. Investigator hypothesize that LiESWT could improve bladder voiding efficiency.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Healthy Volunteers: f
View:

• Bladder voiding efficiency is less than 70%.

Locations
Other Locations
Taiwan
Taichung Armed Forces General Hospital
RECRUITING
Taichung
Contact Information
Primary
Jing-Dung Shen, MD
jdwhydo@gmail.com
+886958878129
Time Frame
Start Date: 2023-08-11
Estimated Completion Date: 2024-12-31
Participants
Target number of participants: 100
Treatments
Experimental: Group-1
Low intensive shockwave therapy 1000 shocks on each acupoint (CV-4, and bilateral ST-28) once a week for 8 weeks.
Experimental: Group-2
Low intensive shockwave therapy 1000 shocks on each acupoint (CV-4, and bilateral SP-6) once a week for 8 weeks.
Active_comparator: Group-3
Oral tamsulosin 0.2mg once daily for 8 weeks.
Related Therapeutic Areas
Sponsors
Leads: Taichung Armed Forces General Hospital

This content was sourced from clinicaltrials.gov